AIM
VCYT icon

Acrospire Investment Management’s Veracyte VCYT Stock Holding History

Acrospire Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-707
Closed -$6K – 1375
2017
Q2 		$6K Sell
707
-7,726
-92% -$63K 0.01% 1938
2017
Q1 		$77K Buy
+8,433
New +$69K 0.06% 520

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acrospire Investment Management's VCYT Position: Q3 2017 in Review

Acrospire Investment Management sold out of Veracyte (VCYT) in Q3 2017, closing a stake of 707 shares — an estimated $6K sold.

Acrospire Investment Management first reported a position in VCYT in Q1 2017 and held it in 2 quarters. The position peaked at $77K in Q1 2017. 87 funds tracked by Wall St. Rank hold VCYT as of Q3 2017.

  • Acrospire Investment Management reported no remaining Veracyte position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 707 Veracyte shares in Q3 2017, an estimated $6K.
  • Acrospire Investment Management first reported a position in Veracyte in Q1 2017 and held it in 2 quarters.
  • Acrospire Investment Management's Veracyte position peaked at $77K in Q1 2017.
  • 87 funds tracked by Wall St. Rank held Veracyte as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.